Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102702124B details a novel zinc-catalyzed route for chiral oxazoline production offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN115785150B reveals a high-yield hydrogenation route for phosphine ligands. This method offers substantial cost reduction and supply chain reliability for fine chemical manufacturing.
Patent CN106432032B reveals a safer PEG-catalyzed route for Levetiracetam manufacturing, ensuring high purity and reduced genotoxic risks for global supply chains.
Patent CN110938084A details a novel NHC-catalyzed route for chiral indolosulfonamides, offering high enantioselectivity and streamlined supply chain solutions for pharmaceutical intermediates.
Patent CN111057058A reveals a safe, room-temperature route for 1H-[1,2,3]-triazolo[4,5-c]quinolines using fluorine catalysis, offering significant cost reduction in pharmaceutical intermediate manufacturing.
Discover high-purity chiral phosphonic amide esters for asymmetric catalysis. Enhance enantioselectivity and reduce costs in pharmaceutical intermediate manufacturing with our scalable solutions.
Patent CN115772508B reveals high-activity DAAO mutants for efficient L-glufosinate intermediate production, offering significant cost and supply chain advantages.
Novel CuI catalytic method for 2-oxazolidinone intermediates. Reduces energy costs and enables scalable pharmaceutical manufacturing under ambient conditions.
Patent CN115448889A details a high-yield Prothioconazole preparation method offering significant cost reduction in agrochemical manufacturing through solvent recycling and mild conditions.
Novel solvent-free method for monophenyl maleate derivatives using solid base catalysts. Reduces cost and environmental impact for pharma supply chains.
Patent CN110396100A reveals a novel nitrogen-oxygen ligand synthesis. Achieve high stereoselectivity and cost reduction in pharmaceutical intermediate manufacturing with scalable methods.
Patent CN101555260B details a safe, high-yield synthesis of Grubbs catalyst using cheap ruthenium salts, offering significant cost reduction and supply chain reliability for olefin metathesis applications.
Patent CN112661794B reveals a stable platinum complex for ortho-alkenylation. This breakthrough offers cost reduction in fine chemical manufacturing and reliable supply chain solutions.
Patent CN112940012A reveals a novel edoxaban preparation method. Achieve high purity and cost reduction in anticoagulant manufacturing with scalable routes.
Patent CN105859800A reveals high-yield chiral ligand synthesis. Discover cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN109956887A details efficient ammoxidation process. Offers high purity intermediates with simplified separation for cost effective pharmaceutical manufacturing supply chains.
Patent CN102827912B reveals a novel two-enzyme one-step method for D-7-ACA production, offering significant cost reduction in antibiotic manufacturing and enhanced supply chain reliability.
Patent CN115160306B details a high-yield DMTMM method for DPP-4 inhibitor intermediates, offering cost reduction and scalable manufacturing for reliable pharma suppliers.
Patent CN110563659A reveals green heterogeneous copper catalysis for triazoles. Enables cost reduction in API intermediate manufacturing and scalable supply chain solutions.
Patent CN112679540B details Na-Phos indole ligand synthesis offering cost reduction and scalable production for high-purity pharmaceutical intermediates.